News Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors Staff September 11, 2023 Continue Reading Previous InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904Next APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF) More Stories Brain Clinical Trial News Pharmaceutical Alzheon Raises $100 Million Series E Financing Round to Advance Development and Commercialization of Oral Tablet ALZ-801/Valiltramiprosate for Treatment of Alzheimer’s Disease Staff June 12, 2024 Healthcare Mental Health News Pharmaceutical Canary Speech Secures $13 Million in Series A Funding to Change How the World’s Top Healthcare Organizations Screen for Mental Wellness and Cognitive Health Staff June 12, 2024 Mental Health News Twenty Percent Of The World’s Employees Experience Loneliness While Global Employee Engagement Stagnated And Employee Wellbeing Declined Staff June 12, 2024
